Status:
UNKNOWN
Virtual Reality as an Adjunct to Management of Pain and Anxiety in Palliative Care
Lead Sponsor:
Riverview Health Centre
Collaborating Sponsors:
Centre for Aging and Brain Health Innovation
Riverview Health Centre Foundation
Conditions:
Cancer
Heart Failure
Eligibility:
All Genders
Phase:
NA
Brief Summary
Virtual reality has been shown to be an effective way to treat pain and anxiety in various different settings. Palliative care is an area of medicine that often deals with patients suffering from pain...
Detailed Description
Virtual reality has been available for many years and is starting to gain traction in clinical setting in varied fields with multiple applications. Some of the primary clinical settings that virtual r...
Eligibility Criteria
Inclusion
- Enrolled on the palliative care program and admitted to Riverview Health Centre Palliative Care unit
- Using 2 or more doses above their regular scheduled dose of opioids and/or benzodiazepines
- Reading/understanding fluency in English
Exclusion
- Patients who cannot wear the headset due to a structural cause (i.e. head and neck malignancy making wearing headset uncomfortable
- Patients who are legally blind
- Participants who cannot tolerate the HMD and VR due to simulator sickness will have to be withdrawn from the study by the investigator.
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2021
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04138095
Start Date
October 1 2020
End Date
March 30 2021
Last Update
March 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Riverview Health Centre
Winnipeg, Manitoba, Canada, R3L2P4